Insider holders · CIK 0001481512
Ra Pharmaceuticals, Inc. · RARX
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Forest Baskett10% Owner | 6,135,234 | 3,490,073 | 9,625,307 | Dec 14, 2018 · 6:22 pm EST | Form 4 |
| Scott D Sandell10% Owner | 6,135,234 | 3,490,073 | 9,625,307 | Dec 14, 2018 · 6:22 pm EST | Form 4 |
| Patrick J Kerins10% Owner | 6,135,234 | 3,490,073 | 9,625,307 | Dec 14, 2018 · 6:22 pm EST | Form 4 |
| David M Mott10% Owner | 6,135,234 | 3,490,073 | 9,625,307 | Dec 14, 2018 · 6:22 pm EST | Form 4 |
| Peter J Barris10% Owner | 6,135,234 | 3,490,073 | 9,625,307 | Dec 14, 2018 · 6:22 pm EST | Form 4 |
| Ravi Viswanathan10% Owner | 5,490,073 | 3,490,073 | 8,980,146 | Feb 21, 2018 · 4:19 pm EST | Form 4 |
| M James Barrett10% Owner | 5,490,073 | 3,490,073 | 8,980,146 | Feb 21, 2018 · 4:19 pm EST | Form 4 |
| NEA Partners 13, Limited Partnership10% Owner | 6,135,234 | — | 6,135,234 | Dec 14, 2018 · 6:22 pm EST | Form 4 |
| NEA 13 GP, Ltd10% Owner | 6,135,234 | — | 6,135,234 | Dec 14, 2018 · 6:22 pm EST | Form 4 |
| NEW ENTERPRISE ASSOCIATES 13 LP10% Owner | 6,135,234 | — | 6,135,234 | Dec 14, 2018 · 6:22 pm EST | Form 4 |
| Rajeev M. ShahDirector | — | 4,858,260 | 4,858,260 | Dec 14, 2018 · 6:14 pm EST | Form 4 |
| Peter KolchinskyDirector | — | 4,858,260 | 4,858,260 | Dec 14, 2018 · 6:17 pm EST | Form 4 |
| RA CAPITAL MANAGEMENT, LLCDirector | — | 4,858,260 | 4,858,260 | Dec 14, 2018 · 6:17 pm EST | Form 4 |
| RA Capital Healthcare Fund LPDirector | — | 4,858,260 | 4,858,260 | Dec 14, 2018 · 6:17 pm EST | Form 4 |
| Jason LettmannDirector | — | 4,066,503 | 4,066,503 | Oct 31, 2016 · 4:51 pm EDT | Form 4 |
| Harry R Weller10% Owner | — | 3,490,073 | 3,490,073 | Oct 31, 2016 · 4:52 pm EDT | Form 4 |
| Krishna Kittu Kolluri10% Owner | — | 3,490,073 | 3,490,073 | Oct 31, 2016 · 4:50 pm EDT | Form 4 |
| Morgenthaler Management Partners IX, LLC10% Owner | 2,745,846 | — | 2,745,846 | Oct 31, 2016 · 4:51 pm EDT | Form 4 |
| MORGENTHALER VENTURE PARTNERS IX LP10% Owner | 2,745,846 | — | 2,745,846 | Oct 31, 2016 · 4:51 pm EDT | Form 4 |
| Novartis Bioventures Ltd10% Owner | 2,251,457 | — | 2,251,457 | Jun 20, 2017 · 4:41 pm EDT | Form 4 |
| NOVARTIS AG10% Owner | 2,251,457 | — | 2,251,457 | Jun 20, 2017 · 4:41 pm EDT | Form 4 |
| A/S Novo10% Owner | 2,031,562 | — | 2,031,562 | Nov 2, 2016 · 4:54 pm EDT | Form 4 |
| Douglas A TrecoPresident and CEO | 218,799 | — | 218,799 | Feb 5, 2019 · 7:38 pm EST | Form 4 |
| Alonso RicardoSee Remarks | 14,285 | — | 14,285 | Mar 6, 2019 · 6:06 pm EST | Form 3 |
| Ramin Farzaneh-FarChief Medical Officer | 7,132 | — | 7,132 | Feb 5, 2019 · 7:38 pm EST | Form 4 |
| David Charles LubnerExecutive V.P. & CFO | 7,126 | — | 7,126 | Feb 5, 2019 · 7:39 pm EST | Form 4 |
| Simon ReadChief Scientific Officer | 6,234 | — | 6,234 | Feb 5, 2019 · 7:39 pm EST | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.